FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170514032> ?p ?o ?g. }

• W2170514032 abstract "Cardiovascular disease is the leading cause of death in Brazil, and hypertension is its major risk factor. The benefit of its drug treatment to prevent major cardiovascular events was consistently demonstrated. Angiotensin-receptor blockers (ARB) have been the preferential drugs in the management of hypertension worldwide, despite the absence of any consistent evidence of advantage over older agents, and the concern that they may be associated with lower renal protection and risk for cancer. Diuretics are as efficacious as other agents, are well tolerated, have longer duration of action and low cost, but have been scarcely compared with ARBs. A study comparing diuretic and ARB is therefore warranted.This is a randomized, double-blind, clinical trial, comparing the association of chlorthalidone and amiloride with losartan as first drug option in patients aged 30 to 70 years, with stage I hypertension. The primary outcomes will be variation of blood pressure by time, adverse events and development or worsening of microalbuminuria and of left ventricular hypertrophy in the EKG. The secondary outcomes will be fatal or non-fatal cardiovascular events: myocardial infarction, stroke, heart failure, evidence of new subclinical atherosclerosis and sudden death. The study will last 18 months. The sample size will be of 1200 participants for group in order to confer enough power to test for all primary outcomes. The project was approved by the Ethics committee of each participating institution.The putative pleiotropic effects of ARB agents, particularly renal protection, have been disputed, and they have been scarcely compared with diuretics in large clinical trials, despite that they have been at least as efficacious as newer agents in managing hypertension. Even if the null hypothesis is not rejected, the information will be useful for health care policy to treat hypertension in Brazil.ClinicalTrials.gov: NCT00971165." @default.
• W2170514032 created "2016-06-24" @default.
• W2170514032 creator A5002691078 @default.
• W2170514032 creator A5004071305 @default.
• W2170514032 creator A5007614613 @default.
• W2170514032 creator A5011567977 @default.
• W2170514032 creator A5013591686 @default.
• W2170514032 creator A5018931040 @default.
• W2170514032 creator A5019971339 @default.
• W2170514032 creator A5020853244 @default.
• W2170514032 creator A5021769707 @default.
• W2170514032 creator A5023045743 @default.
• W2170514032 creator A5026937673 @default.
• W2170514032 creator A5028536954 @default.
• W2170514032 creator A5031830287 @default.
• W2170514032 creator A5035131505 @default.
• W2170514032 creator A5036658421 @default.
• W2170514032 creator A5037735056 @default.
• W2170514032 creator A5038018651 @default.
• W2170514032 creator A5040585049 @default.
• W2170514032 creator A5042311737 @default.
• W2170514032 creator A5042500481 @default.
• W2170514032 creator A5043129288 @default.
• W2170514032 creator A5045803670 @default.
• W2170514032 creator A5053549766 @default.
• W2170514032 creator A5056503708 @default.
• W2170514032 creator A5057054798 @default.
• W2170514032 creator A5057433937 @default.
• W2170514032 creator A5064746262 @default.
• W2170514032 creator A5068233973 @default.
• W2170514032 creator A5078259781 @default.
• W2170514032 creator A5079525983 @default.
• W2170514032 creator A5081367139 @default.
• W2170514032 creator A5082745029 @default.
• W2170514032 creator A5083833392 @default.
• W2170514032 creator A5084181315 @default.
• W2170514032 creator A5090625912 @default.
• W2170514032 date "2011-02-24" @default.
• W2170514032 modified "2023-10-18" @default.
• W2170514032 title "A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial" @default.
• W2170514032 cites W1993647894 @default.
• W2170514032 cites W2054796764 @default.
• W2170514032 cites W2105473163 @default.
• W2170514032 cites W2106366762 @default.
• W2170514032 cites W2108266187 @default.
• W2170514032 cites W2126667051 @default.
• W2170514032 cites W2128684968 @default.
• W2170514032 cites W2144729549 @default.
• W2170514032 cites W2152178651 @default.
• W2170514032 cites W2152798629 @default.
• W2170514032 cites W2172032309 @default.
• W2170514032 cites W2562329777 @default.
• W2170514032 cites W4239047758 @default.
• W2170514032 doi "https://doi.org/10.1186/1745-6215-12-53" @default.
• W2170514032 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3056809" @default.
• W2170514032 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21349192" @default.
• W2170514032 hasPublicationYear "2011" @default.
• W2170514032 type Work @default.
• W2170514032 sameAs 2170514032 @default.
• W2170514032 citedByCount "8" @default.
• W2170514032 countsByYear W21705140322013 @default.
• W2170514032 countsByYear W21705140322016 @default.
• W2170514032 countsByYear W21705140322017 @default.
• W2170514032 countsByYear W21705140322018 @default.
• W2170514032 countsByYear W21705140322020 @default.
• W2170514032 countsByYear W21705140322021 @default.
• W2170514032 countsByYear W21705140322023 @default.
• W2170514032 crossrefType "journal-article" @default.
• W2170514032 hasAuthorship W2170514032A5002691078 @default.
• W2170514032 hasAuthorship W2170514032A5004071305 @default.
• W2170514032 hasAuthorship W2170514032A5007614613 @default.
• W2170514032 hasAuthorship W2170514032A5011567977 @default.
• W2170514032 hasAuthorship W2170514032A5013591686 @default.
• W2170514032 hasAuthorship W2170514032A5018931040 @default.
• W2170514032 hasAuthorship W2170514032A5019971339 @default.
• W2170514032 hasAuthorship W2170514032A5020853244 @default.
• W2170514032 hasAuthorship W2170514032A5021769707 @default.
• W2170514032 hasAuthorship W2170514032A5023045743 @default.
• W2170514032 hasAuthorship W2170514032A5026937673 @default.
• W2170514032 hasAuthorship W2170514032A5028536954 @default.
• W2170514032 hasAuthorship W2170514032A5031830287 @default.
• W2170514032 hasAuthorship W2170514032A5035131505 @default.
• W2170514032 hasAuthorship W2170514032A5036658421 @default.
• W2170514032 hasAuthorship W2170514032A5037735056 @default.
• W2170514032 hasAuthorship W2170514032A5038018651 @default.
• W2170514032 hasAuthorship W2170514032A5040585049 @default.
• W2170514032 hasAuthorship W2170514032A5042311737 @default.
• W2170514032 hasAuthorship W2170514032A5042500481 @default.
• W2170514032 hasAuthorship W2170514032A5043129288 @default.
• W2170514032 hasAuthorship W2170514032A5045803670 @default.
• W2170514032 hasAuthorship W2170514032A5053549766 @default.
• W2170514032 hasAuthorship W2170514032A5056503708 @default.
• W2170514032 hasAuthorship W2170514032A5057054798 @default.
• W2170514032 hasAuthorship W2170514032A5057433937 @default.
• W2170514032 hasAuthorship W2170514032A5064746262 @default.
• W2170514032 hasAuthorship W2170514032A5068233973 @default.
• W2170514032 hasAuthorship W2170514032A5078259781 @default.
• W2170514032 hasAuthorship W2170514032A5079525983 @default.
• W2170514032 hasAuthorship W2170514032A5081367139 @default.
• W2170514032 hasAuthorship W2170514032A5082745029 @default.

• next